Ann has more than 25 years of experience in health economics research and reimbursement policy. She has advised developers of new healthcare technologies in both the medical device and pharmaceutical industries on go-no-go investment decisions and the strategic development of product value message, payment policy and evidence planning, and has effectively led the design, execution and publication of high impact outcomes research studies.

Of note, Ann was instrumental in leading the US and global effort to establish favorable payor policies, affording patients’ access to Transcatheter Aortic Heart Valve Replacement recognized as a top 10 healthcare advancement. In all circumstances she brings a deep understanding of provider, payer and patient needs, and is skilled in aligning these critical stakeholder interests to ensure patients have appropriate access to care.

She holds a BSN from the University of Kansas, Kansas City, KS and an MBA from Washington University, St. Louis, MO.